Previously writing on ‘Wildwood’ ('pizza, pasta, grill') and ‘dim t’ (pan-Asian) casual dining restaurants company Tasty (TAST), in June with the shares down from previously 5.5p to below 4p I noted share price performance tasty for the CEO, not for other investors!, concluding that ‘with £135,000 basic salary apparently not enough to sufficiently incentivise and the noted challenges now, continue to avoid / sell’. The shares most recently closed at 2.6p… and now results for the company’s year ended 25th December 2022.

Previously writing on company describing itself as “a leading vendor of cloud-based cybersecurity and IT automation software” Osirium Technologies (OSI), in January with the shares at 3.8p I concluded that it was still cash burn and thus only a bailout fundraise for now. The shares last closed at 2.6p and are currently further lower on the back of full-year results... which have a main body of the statement omission disgrace.

Previously writing on group which describes itself as “a leading UK provider of Managed IT services and communications solutions to private and public sector organisations”, CloudCoCo (CLCO) with its shares up to 1.325p I noted argues “strong strategic and commercial progress”…but if EBITDA is bullshit earnings, what is “Trading EBITDA”?!. The group now states that it “is pleased announce its full year results for the year ended 30 September 2022”, so what of a now 1.25p share price?

Previously writing on antibody contract research organisation Fusion Antibodies (FAB), last month I noted the shares rising from 45p on an “R&D update”, but wrote attempted ramptastic?, how “sufficient” is the cash now?. Today a “trading statement” and the shares currently more than 30% lower towards 30p.

Previously writing on company describing itself as “a leading UK developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets” AMTE Power (AMTE), in September with the shares down towards 70p I concluded sceptically. The shares most recently closed at 54p, but what of a “Delivery of Ultra Prime Cells” announcement today and the shares currently up towards 60p, an above £21 million market cap?

Previously writing on transplant platform company Verici Dx (VRCI), in September with the shares falling to 17.5p I reviewed was the fundraise for accelerated progress or to avert cash crunch ahoy?, concluding continue to avoid. The shares most recently closed at 7.5p, but what of them currently up 20% today on the back of a “CLIA Certificate of Compliance” announcement.

Previously writing on company describing itself as “a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems” CAP-XX (CPX), last month with the shares down to 3.4p I noted “current funding is sufficient for the company's expected needs”… For how long though?. Today results for the company’s half-year ended 31st December 2022… and the shares currently further down to 2.6p.

Previously writing on company which describes itself as “a leading global manufacturer of utility-grade energy storage” Invinity Energy Systems (IES) last month with the shares falling towards 40p I noted cash burn concerns and now, quelle surprise, the company “is pleased to announce the results of the placing”. How ‘pleasing’ is it?

Previously writing on digital technology platform for retailers group Itim (ITIM), in September with the shares down to 67.5p I questioned ‘deployment of its products and services vital in helping clients weather the storm’, concluding still avoid/sell and ANOTHER 2021 AIM IPO (at 154p) Roll-Call of Shame. The shares last closed at 49.85p and today a further “trading update”.

Previously writing on company describing itself as a “leading esports solutions provider” Gfinity (GFIN), last month with the shares up to 0.545p I cautioned ‘commercial agreement ‘delight’. Attempted ramptastic?’. Now an intra-day (uh oh!) “Business update and financing” announcement.

Previously writing on antibody contract research organisation Fusion Antibodies (FAB), in August with the shares rising above 100p I wrote ‘ramptastic patent application announcement, cash sufficient for current requirements?’. The shares have since slumped to most recently close at 45p, but what of an announcement today taking them up currently more than 5.5%?

Previously writing on surface coating technology company Hardide (HDD), in September with the shares at 19p I concluded including that it will be interesting to see the full-year results and balance sheet detail, but they clearly aren’t going to be good. The company has now announced the results, stating that it “is pleased to report” them and that “the new financial year has started well, with revenues in the first quarter ahead of those in the same period last year”. So what of a now 13.5p share price?

Previously writing on Engage XR (EXR), two weeks ago with it describing itself as “a leading metaverse technology company”, I concluded to be particularly wary of announcements such as its latest “showcases first AI-powered virtual employee”. Now a “pleased to announce… placing”. Quelle surprise!

Previously writing on radiation and bio-detection technology group Kromek (KMK), last month with the shares up to 11p I concluded that, with financial and valuation concerns, I avoided. Today it has announced a c. £2.5 million funding award “from the UK's innovation agency, Innovate UK” (of Versarien (VRS) infamy) and half-year ended 31st October 2022 results… and what of the shares in response currently a further near 10% lower to 9.35p?

Previously writing on innovation management software and services company Sopheon (SPE), 17 months ago with the shares rising above 925p I concluded that I wasn’t prepared to pay a market cap of more than £100 million at that stage of ‘SaaS transition’ here. The shares most recently closed at 625p but are currently up to 680p on the back of a trading update. So what’s the situation now?

Previously writing on group which described itself as a “disruptive and inclusive digital womenswear fashion brand” In The Style (ITS), I reviewed what of a now 13.625p share price as the CEO swiftly exited and a strategic review was announced but it argued “considerable potential… the current market capitalisation of the company does not properly reflect”? I concluded, noting its trading trajectory, reiterating to avoid… and now an intra-day (uh oh!), 12:54pm, “trading update”.

Previously writing on currently Hotter Shoes brand 55+ demographic footwear group Unbound (UBG), in August with the shares at 14.75p I noted, following an equity raise it stated would see it “focus on accelerating our growth strategy”, that following the prior misleading market expectations, I remained highly sceptical. Having last closed at 6.75p, today a “Trading Update and Operating Review”.

Previously writing on alcoholic drinks company Distil (DIS), in October as the falling shares saw the market cap down to below £6 million I cautioned still due to stated “opportunity for new growth” and “a new, highly effective distributor” having to be proven and amidst an admitted backdrop of macro uncertainty and cost pressures. The last closing market cap was just above £6 million… but then today a “trading update”.

Previously writing on models and collectibles company Hornby (HRN), in April with the shares up to 34.5p I continued to avoid noting it looks to remain that the valuation demands some strong growth in profitability. The shares last closed at 29p and are currently further down to 24p, so what about a latest “trading statement”?

Previously writing on 'Fridays' (formerly TGI Fridays), '63rd+1st', and 'Fridays and Go' restaurants and bars company Hostmore (MORE), in November with the shares at 15.245p I questioned how effective its “elevating our positioning” is going to be against current headwinds. Today a “Trading Update and Board Change” announcement… and the shares currently slumping from a last close above 14p to below 11.5p, so what’s the detail?

Previously writing on “materials and textile innovation” company HeiQ plc (HEIQ), in October with the shares at 72p I noted receivables and cash generation concerns and concluded to certainly avoid. The shares are currently slumping to well below 30p on the back of a “Trading Update and Acquisition” announcement.

On the ‘no one watching o’clock’ day of 30th December Invinity Energy Systems (IES) issued a “Project Delivery Update” which helped the shares up 13.5% to 43p as it included that the company “now anticipate revenues in 2023 significantly ahead of its previous expectations” and that “the prospects for our battery systems have never been more positive”. However, I concluded that it was also a trading warning for its year ending 31st December 2022 and asked how bad was the cash burn in the second half of the year then?. There are now some broker “estimates revised” and the shares are currently slipping back.

Previously writing on company which describes itself as “a world-leading esports technology and media business” Gfinity (GFIN), in March with the shares at 1.425p I noted interims, the equity raise “for working capital purposes”?, concluding continue to avoid. Now it announces results for its year ended 30th June 2022 headlined “Continued progress on path to profitability”. Why announce the results now, at prime no one watching o’clock, then?

Last month I questioned on ‘Virtual reality technology company’ Engage XR (EXR) argues “a huge moment for the group”, but how “successful” is this evolution to be?, concluding with the shares up to 15p ‘I look forward to seeing just how “strong” the cash position remains at the year-end… certainly at this juncture, avoid / sell’. The shares last closed at 13p…and today a “trading update” and they’re now plummeting.

In September I noted group describing itself as a “disruptive and inclusive digital womenswear fashion brand”, In The Style (ITS) argued “significant progress against several of the strategic priorities” but I questioned what about the still diminishing cash though?!. That was with the shares at circa 26.5p, so what of a now 13.625p share price after further announcements today?

Previously writing on company describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA), in October with the shares up to 89.5p I concluded that its recent announcements and above £59 million market cap meant that I retained caution, still avoid/sell. The shares last closed at 83.8p but are currently falling well below 80p on the back of a “trading update”.

Previously writing on ventilation systems and window and door hardware company Titon Holdings (TON), in July with the shares down to 75p I noted my prior caution justified; trading warning – concluding that uncertainties saw me continue to avoid. The shares last closed at 81p... but today another trading update.

Previously writing on windows and doors retailer and manufacturer Safestyle UK (SFE), in September as the shares fell to 21.5p I concluded that ‘its high household energy costs environment confidence for its products is versus the consumer spending pressures and “consumer confidence levels at a 40-year low”. As such, I remain highly cautious here at this juncture and continue to avoid’. The shares last closed at above 30p but are currently falling back below 25p following a “trading update”.

Describing itself as “a leading international developer and manufacturer of high quality, rapid diagnostic tests”, Abingdon Health (ABDX) has announced results for its year ended 30th June 2022 with CEO Chris Yates arguing “as a knowledge leader in lateral flow, and with our comprehensive contract service offering, we believe we are well-placed to support customers in bringing their products to market and grow our business”. So why are the shares currently 12.5% lower today to 5.25p?

A trading update from Pod Point Group (PODP) early this year commenced by describing the group as “one of the UK's market leading providers of Electric Vehicle charging solutions”, another such update today commences that “The long-term market for Plug-In-vehicles continues to be attractive as the industry grows towards electrification in the UK by 2030”. Good news then?

Describing itself as “a pioneer in solid-state battery technology”, Ilika plc (IKA) has issued an update following its half-year ended 31st October 2022 including that “M300 product qualification is now expected to complete in Q2 calendar year 2023… ramp-up is now expected to take five years to reach capacity of the UK manufacturing facility”. What does it mean financially?

Previously writing on energy services technology and equipment company Enteq Technologies (NTQ), in September with the shares at 10p I concluded a ‘current troubled state… still avoid / sell’. What of now results for its half-year ended 30th September 2022, with the shares slightly below 10p and a £7 million market cap?

Describing itself as a “technology and services business aiming to revolutionise home moving and ownership”, Smoove (SMV) has announced results for its half-year ended 30th September 2022 with “Highlights” including “revenue increased by 4% to £10.6m… Cash balance of £17.0m… Proposed tender offer to return up to £5m to shareholders to be launched as soon as practicable… confident that we have the right strategy and plan in place to build on the successes of the first six months of this financial year”. So why currently a share price response down approaching 7% to 33.8p?

A “New Contract Win” announcement from Insig AI (INSG), commencing that it “is pleased to announce that a London based alternative investment manager with in excess of $1 billion of assets under management has signed a consultancy agreement that will draw on Insig AI's fintech data science capabilities”. Sounds good, and what of a share price response currently up to 18.25p?

‘Virtual reality technology company’ Engage XR (EXR) has announced what CEO David Whelan argues “is a huge moment for the group. We are now a leading metaverse technology company that can help make the metaverse strategies of leading global organisations a reality”. What’s the detail and what of a share price move currently 5.3% higher to 15p?

Previously writing on “data science and machine learning company” Insig AI (INSG), in August with the shares at 22p I noted that, despite being down from above 40p when I previously wrote, with further access to finance looking to be required still avoid / sell. So what now on the back of a “Trading update” – and the shares currently further down to 18p, a £19 million market cap?

Digital chemistry data and software group DeepMatter (DMTR) has issued a trading update and an announcement that it is “delighted to announce an important licensing agreement with Merck” – and the shares have currently responded to 0.14p, 80% higher!

Previously writing on Fulcrum Utility Services (FCRM) in May with the shares at 7.3p, despite it stating that its “core multi-utility contracting business has remained relatively unaffected by… the UK energy market has continued to experience considerable turbulence”, I concluded that I’d want some clear evidence of an overall turnaround before considering a positive stance. Today a further trading update.

Describing itself as “a world leader in Narrowband Radio Frequency Smart Mesh Networks”, CyanConnode (CYAN) has announced it has raised £0.5 million via a share subscription at 12.25p per share – stating “considering these uncertain times, your board felt it prudent to accept the offer, the proceeds of which will be used to bolster working capital”.

Previously writing on flexible workspace technology company essensys (ESYS), in August with the shares up to 63p I questioned is it really “good progress against its strategic growth plan”?. What of now results for its year ended 31st July 2022 and the shares currently down to 52.5p?

Behavioural science-based business improvement company Mind Gym (MIND) has issued a trading update headlined “Significant H1 momentum driving growth in H2 and FY24”. So what of a current share price response up to 97.5p?

Previously writing on alcoholic drinks company Distil (DIS), in July with the shares down to 1.15p I concluded that I remained cautious of the trading and financials here and continued to avoid. The shares last closed at 1.05p but are currently falling materially further on the back of half-year results.

Previously writing on fishing retailer Angling Direct (ANG), in August with the shares down to 30p I concluded that the trajectory of trading saw me retain my cautious stance of most recently a 62p share price. The shares most recently closed at 32p but are currently below 30p on the back of half-year results.

Writing on “materials and textile innovation” company HeiQ plc (HEIQ) last month, I noted that though it argued “significant amounts of receivables have been collected after balance sheet date… we expect several projects to start adding sales in the remaining months”, a still not far off £95 million market cap still very much looked a lot. Now a “Files Breach of Exclusive Agreement Complaint”-titled announcement from the company.

Writing on B2B media group Bonhill (BONH) last month with the shares at 5.25p, I questioned its ‘pleased to announce, robust’ first half argument. The shares last closed at 5.75p...but are currently down towards 4p, so what’s going on?

‘Drug treatment regimens and personalised medicine consultancy’ Physiomics (PYC) has followed recent half-year results with a “pleased to announce… third contract by existing client, Numab Therapeutics”. So what of a current 2.3p share price?

Writing on company which describes itself as “a leading producer and supplier of graphene-based products for use in consumer and industrial markets” Directa Plus (DCTA) at the start of this month with the shares just below 90p I concluded, ahead of the half-year financial detail, still avoid / sell. So what of the now-announced results and the shares more than 12% lower at 76.5p?

Manufacturer of carbon fibre reinforced ceramic automotive brake discs Surface Transforms (SCE) “is pleased to announce that… the company has conditionally raised gross proceeds of £16.0 million… at the issue price of 40 pence per ordinary share”. How pleasing is this?

Describing itself as a “technology and services business aiming to revolutionise home moving and ownership”, Smoove (SMV) has announced “strong growth… demonstrates the depth of the group's relationships with its introducers and its ability to capture market growth in the remortgage segment” and that it “anticipates that the recently announced changes to stamp duty thresholds will help more people get on the property ladder which should in turn positively impact the group”. So what of a current share price response to below 44p, down 9%?

Previously writing on company which describes itself as “a world leading specialist in high-end embedded computer products for critical applications” Concurrent Technologies (CNC), in May with the shares falling below 80p I noted “order book increased”… but what about order delivery ability?, stating component shortage potential for disappointment. The shares last closed at 83p but are currently falling towards 70p on the back of half-year results.

Describing itself as a “disruptive and inclusive digital womenswear fashion brand”, In The Style (ITS) has issued an “AGM Trading Update” arguing “significant progress against several of the strategic priorities”. So what of a little changed circa 26.5p share price?

Previously writing on digital technology platform for retailers group Itim (ITIM), in April with the shares up to 114p I concluded that the valuation saw me avoid and I’d monitor to see if this just June last year-listed group could deliver progress at least as expected. The shares last closed at 83.5p... and now results for the first half of 2022.

Previously writing on medical monitoring technology group Deltex Medical (DEMG), in July with the shares down to 1.10p I wrote emphasises higher revenue, but how’s the balance sheet?!. What of now results for the first half of 2022 and a 0.925p share price?

Previously writing on finnCap Group (FCAP), in April with the shares down to 26.5p I noted the outlook looked set to be even further of ‘more complex markets’ for it and to avoid from a still more than £47 million market cap. What now after a further trading update, with the shares currently down to 16.5p?

SRT Marine Systems (SRT) has announced that its AGM and presentation on Wednesday will also be live streamed and will be preceded by an open day at the company's offices. That is creditable investor relations but what about a share price down from approaching 50p early this year to a current below 25p following its full-year results?

Previously writing on provider of business technology jargon(oops) an “intelligent operations platform for the deskless worker” Checkit plc (CKT), last month with the shares at 27.5p I concluded to avoid including with market conditions now being adverse to cash burn and jam tomorrow hopes. It has now announced results for its half year ended 31st July 2022, including emphasising “continued to deliver against its strategy to transition the business exclusively to higher quality and higher value recurring revenues”... so what of a now 20p share price?

Previously writing on B2B media group Bonhill (BONH), in June with the shares at 6p I concluded that it would be interesting to see the full half-year picture with the underlying cash burn. It has now announced results for the first half of 2022...and the shares are at 5.25p.

Previously writing on transplant platform company Verici Dx (VRCI), in June with the shares down to 26p I questioned was the “fundraise to… continue the accelerated progress” or to avert cash crunch ahoy?. Now half-year results... and the shares currently further down to 17.5p.

IQE plc (IQE) has announced results for the first half of 2022, arguing “the business has demonstrated resilience” and “strong progress” against its strategic transformation goals. Really?

Describing itself as “a leading manufacturer of battery cells for specialist markets”, AMTE Power (AMTE) states that it “is pleased to announce that… Alan Hollis has been appointed to the board… has a 20 year public company track record of developing and executing profitable growth strategies within engineering and manufacturing businesses with turnovers ranging from £4m-£200m”. So what of a current more than 3% lower share price response towards 70p and a £25 million market cap?

Describing itself as “a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products”, Itaconix (ITX) states that it “is pleased to announce a new global agreement with Croda Inc. in odour control”. What of a share price response currently over 5% higher to 5.10p?

Digital chemistry data and software group DeepMatter (DMTR) has announced results for the first half of 2022 emphasising that its “concept of providing our customers with easy access and the ability to exploit data, is gaining international industry recognition. A combination of a growing pipeline and our H1 investment programme is expected to drive deal-flow in H2”. So what of a currently little changed 0.11p share price, £4.4 million market cap?

Describing itself as “a leading global software and technology provider delivering digitally enabled buildings, spaces and services for landlords and flex workspace operators”, essensys (ESYS) states that it “is pleased to announce a pre-close trading update for the financial year ended 31 July 2022” and “revenue and adjusted EBITDA in FY22 are expected to be in line with consensus market expectations… we remain confident in the market and opportunity for the group in FY23 and beyond”. So what of a share price response currently up just over 4% to 63p?

Yesterday CyanConnode (CYAN) emphasised a “largest-ever order” but I noted ramptastic over financial detail again. So what of now results for its year ended 31st March 2022?

Microsaic Systems (MSYS) “is pleased to announce that Kingfield Electronics Limited has appointed Microsaic as an Authorised Partner for front-end research, development, and engineering product development in scientific instrumentation and micro-engineering”. What of a current 0.08p share price, to a circa £5 million market cap, in response?

Rosslyn Data Technologies (RDT) has announced a contract which CEO Paul Watts argues “highlights the value of our partnership with Chain IQ and endorses our strategic decision to focus on a partner-led go-to-market approach”. With the shares currently up approaching 10% to 2.3p in response, a £7.8 million market cap, what’s the detail?

Previously writing on ‘immersive entertainment’ group Immotion (IMMO), in June with the shares at 3.7p I questioned just how “strong” is the trading?. Does now a “Pre-Close Trading Update” help?

Describing itself as a “leading in-content advertising company” and stating it is “tracking strongly against the KPIs and are seeing a very clear acceleration of interest in the in-content format”, Mirriad Advertising (MIRI) has announced first half of 2022 results. So what of a 7.75p share price – down from a start of year 28p!?

Previously writing on provider of business technology jargon(oops) an “intelligent operations platform for the deskless worker” Checkit plc (CKT), in February with the shares down to 46p I noted it increasing costs with it already cash burn aplenty and how long to wait for a meaningful positive revenue and bottom-line swing?, avoid / sell. The shares last closed at 29p and now a trading update emphasising “successful transformation into a subscription business… Cash at 31 July 2022 was £19.5m… in light of market conditions, the board is accelerating its plan to achieve profitability”... and the shares currently at 27.5p?

Cyber security group Falanx (FLX) has issued a trading update noting full-year organic revenue growth of circa 14% and “the pipeline is not only much larger in terms of financial value but also has a high level of advanced prospects”. So what of a current approaching 22% share price rise to 0.70p?

It never ceases to amaze me how easily some of the micro cap shares get pumped, and how willing some people are to buy even after a huge increase in the share price on no actual news.

Superyacht painting, supply and maintenance company GYG plc (GYG) has announced proposed cancellation of its shares on AIM and re-registration as a private limited company, arguing that a number of factors have impaired investor sentiment towards it and noting legal and regulatory burdens associated in maintaining the stock market listing. So what now, with the shares currently approaching 35% lower at 20.5p?

Previously writing on engineering and technical recruitment group RTC (RTC), in March with the shares down to below 30p I concluded the financials including cash burn and near term difficulties meant I certainly continued to avoid. So what now with “pleased to announce” results for the first half of 2022 and the shares at 21.5p?

Previously writing on ventilation systems and window and door hardware company Titon Holdings (TON), in May with the shares at 75p I noted supply chain, inflationary and consumer pressures and economic activity uncertainty saw me continue to avoid. The shares last closed at 82.5p but are currently back to 75p, a £8.4 million market cap, on a “trading update”.

Thursday was a busy day with a thousand (and one) corporate names reporting and the European Central Bank finally seeing common sense and raising interest rates after 14 years to (wait for it!) 0%. What a world we live in… And talking about the excitable world out there brings me back (again) to Ocado (OCDO). Last month - despite being an occasional user – I noted it is still bonkers that the grocery technology name has a c. £6.5 billion market cap (even if it continues to sign various global deals). What did Ocado’s first half 2022 numbers say yesterday then? No surprise it is still talking about losses (and hopes for the future).

Allergy Therapeutics (AGY) has issued a trading update for its year ended 30th June 2022 emphasising “effective cost controls implemented alongside the group's significant clinical progress” and “in 2023, sales are expected to return to their previous near double-digit growth levels”. So what of a current share price response to 17p, approaching 7% lower?

DP Poland (DPP), with the exclusive right to develop, operate and sub-franchise Domino's Pizza stores in Poland, states it is “delighted to see the strong sales performance achieved in the first half of 2022 continuing” and is “confident we will emulate the success of the brand in other markets”. But what’s the detail?

IQE plc (IQE) states it is “pleased we have met our expectations and commitments for H1 2022… the group's view of the full year remains unchanged”. With it describing itself as “the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry”, this good news then?

Having previously closed at 1.55p, shares in Guild Esports (GILD) reached 2p earlier today – and this has now seemingly forced from the company a “Statement regarding recent share price movement”.

Retail, promotional and ‘brand experience’ company SpaceandPeople (SAL) has announced “trading during H1-22 continued to recover… confident that this will continue into the traditionally busier second half of the year”. So what of a current share price response to 112.5p, up 12.5%?

Biopharma technology company Physiomics (PYC) has announced its year ended 30th June performance “in-line with market expectations” and expected increased revenue this year. So what of a current share price response more than 5% higher to above 3p?

Medical monitoring technology group Deltex Medical (DEMG) has issued a half-year trading update including “revenues for the six months ended 30 June 2022 increased approximately 9%” and that it expects to drive higher revenues. So what of a share price currently down more than 4% to 1.10p in response?

Previously writing on ActiveOps (AOM), in March with the shares down to 97.5p I concluded that with the valuation still a significant premium on tangible metrics I’d still currently avoid. With the shares having last closed at 74p and the self-described “leading provider of Management Process Automation software” now “pleased to announce its unaudited results for the financial year ended 31 March 2022”, what’s the outlook from here?

Describing itself as “a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products”, Itaconix (ITX) has issued an AGM statement emphasising “revenues substantially ahead of any prior half year. Demand has remained strong right into this week”. So what of a current 5.75p share price, circa £26 million market cap – approaching 30% ahead on this latest announcement from the company?

Previously writing on ‘immersive entertainment’ group Immotion (IMMO), with the shares rising above 6p in August last year I concluded that financial factors had seen me remain cautious and that with the market cap above £25 million I continued to avoid. So what of today a “pleased to provide” AGM trading update... and the shares at 3.7p?...

Microsaic Systems (MSYS) has issued a “pleased to announce” trading update, emphasising that “the launch of the Microsaic Services Division, earlier this year, has resulted in an uplift of 40% in revenues” and “a healthy order book for H2 2022 which is the strongest ever going in to the second half”. So what of a current little changed 0.08p share price, circa £5 million market capitalisation?...

Previously writing on a “trading update” from XP Factory (XPF), in January with the shares at 30.5p I questioned what about the bottom-line result and balance sheet? Today an AGM Statement from the company – and the shares currently further down to below 18p. So what’s the situation now?...

As many of you reading this will know, I’m not exactly a fan of Mode Global Holdings (MODE) and even less so after its latest antics where it hasn’t exactly gone out of its way to inform investors about its latest fundraise!

Software for customer marketing company Pelatro (PTRO) has issued an AGM Statement including that “contracts announced in the last month in both the telco and the non-telco space demonstrate our continuing success in building the group's recurring revenue base… we are confident of delivering a performance in line with expectations for 2022”. So what of a share price of 27.75p, down from above 40p last Autumn?...

B2B media group Bonhill (BONH) has announced a “Business Disposal & Trading Update” including that it is now “pleased with the performance… excited by the opportunities and financial performance that the new streamlined business presents”. So what of the shares at 6p, down from above 10p early this year?...

Writing on Xeros Technology Group (XSG) last week as the shares rose above 70p I concluded ‘with this share price spike towards a £17 million market cap, I’d… be particularly wary – also with financial results scheduled for next Wednesday. Certainly ahead of that, I continue to avoid’. Hopefully that was heeded as the shares last closed at 41.5p and are currently below 40p on the back of the 2021 results announcement. So what’s the news?...

Previously writing on ‘digital analytics-as-a-service’ company Actual Experience (ACT), in December with the shares falling to 40p I concluded with it already burning cash at an alarming rate that hopefully my prior warnings were heeded and, natch, that the shares were a sell. Now a “Contract cancellation” announcement at no one is watching o’clock, 6.30PM, on Friday. Uh oh!

Previously writing on behavioural science-based business improvement company Mind Gym (MIND), with the shares at 130p in April I concluded that the valuation didn’t look to leave scope for the uncertainty and downgrades and therefore to still avoid / sell. Today it “is pleased to announce its audited results for the year ended 31 March 2022”...and the shares are 120p. Hmmm...

Previously writing on transplant platform company Verici Dx (VRCI), in March I concluded ‘if the cash is not soon needed, why place now? With the cash burn and a pre-fundraise market cap at even the current 36p share price of above £51 million, avoid’. With a “Commercial Team Appointments” announcement now following results, what do I think now?...

Previously writing on company which describes itself as “a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products”, Itaconix (ITX) in April with the shares above 5p I concluded ‘with, I suggest, further bailout funding still likely to be required, still avoid / sell’. So what of today-announced full-year results?...

Eve Sleep (EVE), under a “Strategic and financing options review” heading, states this is with it “having delivered a third consecutive year of growth in revenues and marketing contribution in our core UK & Ireland business in 2021, and cognisant of current trading conditions, the board now wishes to accelerate eve’s push into the wider sleep wellness space” and following “recent inbound investor interest”. So what of a current approaching 25% lower share price response to 1.25p?...

The fraudsters at Eden Research (EDEN) have served up calendar 2021 numbers and laughably claim that the company has enough cash to last another 12 months. If so I am a banana. The claim is patently not true.

Previously writing on Microsaic Systems (MSYS), last month with the shares at 0.10p I questioned how significantly really does a new agreement illustrate how it is able to access additional revenues from innovative companies and concluded I’ll therefore review its eventual full-year 2021 results announcement and the overall outlook with it with interest whilst then continuing to avoid. It now “is pleased to announce its audited financial results for the year ended 31 December 2021”...

RUA Life Sciences (RUA) states that it “is pleased to provide an update for the year ended 31 March 2022 together with current trading, regulatory and operational updates, ahead of the publication of the group's audited final results for the year ended 31 March 2022, which are expected to be released mid-July”. So what of a current 7.5% lower share price at 43p?...

Medical analytics company IXICO plc (IXI) has announced results for its half-year ended 31st March 2022, including that it now anticipates that it will “materially exceed” market profit expectations for the full year. So what of a current 37.5p share price, down more than 9%?!...

Previously writing on marketing software company Pelatro (PTRO), in January I questioned “in line with expectations”. It now “is pleased to announce today its audited results for the year ended 31 December 2021”, so what’s the story?...

‘Digital chemistry data and software’ group DeepMatter (DMTR) states that it is “delighted” to be working with Springer Nature to provide the “leading global research publisher” with products and services making sharing research data faster, easier and more impactful. So what of a current more than 4% higher share price response to 0.12p?...

Medical technology group Deltex (DEMG) has updated on its AGM that “there are encouraging signs that the group's revenues in the UK and USA are beginning to recover”. So what of a current 1.10p share price?...

Cyber-defence group GRC International (GRC) has announced a trading update including year-ended 31st March 2022 “billings up 21% to £14.8m… Q4 billings up 25% to £4.5m… EBITDA of at least £0.8m… year-end cash £2.0m (2021: £0.2m)” and “strong momentum in Q4 and cash generation have continued into the start of the new financial year”. So what of a share price up to 29p?...

DP Poland (DPP) has stated in a trading update that it is “delighted to see the strong sales performance in Q1 2022, with LFL System Sales up 21% over 2021, benefitting from a strong management focus towards increased order volumes in our stores. At the end of March 2022, Poland lifted the majority of COVID-19 restrictions and we have seen a further acceleration in sales growth, with LFL System Sales up 29% in March”. So what of a current share price response slightly lower to 7.75p?...

Describing itself as “a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products”, Itaconix (ITX) states that it “is pleased to update the market on current trading”. So what of the detail and a currently slightly higher to 5p share price?...

A “New contract, fundraising and Indian developments”-titled announcement from CyanConnode (CYAN) has currently helped the shares up nearly 15% today to 19.25p. So material news?

Previously writing on provider of online search, merchandising and personalisation solutions for ecommerce Attraqt Group (ATQT), in July with the shares at 42.5p I noted my previous review noting underlying cash burn and that the valuation looked at least to have very little scope for any trading disappointment. So what of 2021 results announced today?…

Previously writing on B2B media group Bonhill (BONH), in July with the shares falling below 13p I concluded that, with much near-term recovery needed to meet forecasts, only on my watchlist. Today a “Directorate changes, Fundraising & Trading Update” announcement – and the shares currently further lower to 5.5p.

A “Directorate Change and Management Updates” announcement from Diurnal Group (DNL) includes that David Bevan, with over 30 years of broad base expertise in the industry, has been promoted to a newly created role of Chief Business Officer. Though, with shares in the group currently down more than 4.5% to 15.25p, what else does the announcement include?…

Describing itself as a “leading in-content advertising company” Mirriad Advertising (MIRI) has made a “In-content advertising increases reach”-titled announcement and the shares have currently responded more than 27% higher to 22p. So what’s the news?…

Just over two weeks ago Gfinity (GFIN) announced a £2.7 million equity raise “for working capital purposes”. I questioned a “world leading esports solutions provider” requiring £2.7 million… and so what about now-announced results for its half-year ended 31st December 2021?…

Describing itself as “a world leader in narrowband radio frequency smart mesh networks”, CyanConnode (CYAN) has announced new funding which it states “allow us to maintain momentum and win some of the large opportunities being presented to us” – and the shares have currently responded up to 16.5p. This though follows I previously questioning “solid progress” or continuing cash burn? (And what about the borrowings?!) with the shares falling below 21p in January. So what now?…

An end-February update from McColl’s Retail Group (MCLS) included that it “expects FY22 adjusted EBITDA to be slightly behind current market expectations, and net debt in the region of £100m at the end of FY22”. Now a “Directorate Change”…

Hormonal diseases-targeting pharmaceutical group Diurnal (DNL) has announced results for its half-year ended 31st December 2021 including “Alkindi product sales (including royalties) for the period increased to £1.74m, representing year-on-year growth of 46%… Efmody initial product sales for the period of £0.39m were in line with the company’s expectations”. So why a share price response to below 18p, more than 46% lower?!…

Previously writing on “video optimisation platform company” SEEEN plc (SEEN), in August with the shares down to 44p I concluded cautiously with that there looked much potential already discounted by the valuation. What now after it “pleased to announce a repositioning of roles for executive members of SEEEN’s board and other proposed appointments to build on the company’s momentum with respect to customer wins and its recent strategic partnership with Kinetiq, Inc.”, but the shares further down… to 16.5p!?…

Self-described “a world leading esports solutions provider”, Gfinity (GFIN) has announced “it has conditionally raised £2.70 million… at a price of 1.25 pence per share. In addition, for every new ordinary share, subscribers in the fundraising will be issued with one warrant to subscribe for one ordinary share at the issue price. The fundraising proceeds will be used for working capital purposes… The issue price represents a discount of 2.3 per cent. to the previous day closing share price of 1.28 pence per share”. Hmmm – a “world leading esports solutions provider” requiring £2.7 million?…

At the start of this month Mobile Streams (MOS) was “delighted to announce its monthly revenue now exceeds $150,000 per month across all channels. This is an increase of 87.5% in monthly revenue since the company’s update on 1 December 2021”. However, revenue is, of course, vanity and today “Placing and Proposed partnership”…

On 21st February Fusion Antibodies (FAB) announced the resignation of CEO Richard Jones, though stating “Richard will remain with the company while arrangements are put in place for his successor. The board has initiated a formal search for a new CEO”. It has today announced that “Richard Jones has now stepped down from his role as CEO, effective from 11 March 2022”. Who’s the successor then?…

Engineering components coatings company Hardide (HDD) is “delighted that the first half of the year has started strongly with sales expected to be over 40% higher than the same period last year… optimistic that the increasing demand from existing customers and the high-volume potential of a number of projects will result in the group achieving its previous upward sales trajectory”. The shares have responded up to 33.5p, but what does the company’s AGM update mean financially?…

Describing itself as “a world-leading video game media and technology business”, Gfinity (GFIN) has announced an “Update on first half performance” including emphasising “strong progress made during H1 in the areas of greatest strategic value”. So why currently a share price of 1.225p, down 49%?!…

Biopharmaceutical data analytics company IXICO (IXI) has announced it has been selected for an open-label Phase I/II dose finding study, emphasising it “reflects the confidence of our clients in the use of our services”. So what of a share price slightly ahead to 43.5p, but comparing to 58.5p in December?…

Verici Dx (VRCI), a developer of clinical diagnostics for organ transplant, has announced a placing of “at least £10.0 million” at 35p per share, stating it “intends to use the net proceeds of the fundraise to… continue the accelerated progress the company has experienced to date”. So what of currently a 4% share price fall in response?…

A trading update from infection prevention and control-focused company Byotrol (BYOT) commences, “Our second half performance (six months to 31 March 2022) is showing a significant improvement in product sales compared to our first half, and the order book remains strong into year end” and includes “if we do not conclude any large IP sales, we would expect overall revenues to be no less than £6m, with positive underlying EBITDA for the year… we expect our cash position at year end to be no less than £1m”. The shares have currently responded up to 3.15p, but what of they still down from above 5p as recently as December?…

Provider of business technology jargon(oops) an “intelligent operations platform for the deskless worker”, Checkit plc (CKT) has announced a trading update including “the group delivered bookings growth of 95%… Cash at 31 January 2022 was £24.2m (31 January 2021: £11.5m)… The board remains confident in the significant opportunities presented by the growing deskless worker industry”. So what of a share price of 46p, down from 66p reached last year?…

Shares in company describing itself as “a leader in plant-based specialty polymers used as essential ingredients in everyday consumer products” Itaconix (ITX) are currently more than 18% higher on the day to 5.85p, so what’s the news?…

‘Smart’ buildings and commercial spaces software company SmartSpace (SMRT) is “pleased… results for the full year ending 31 January 2022 are expected to be slightly ahead of market expectations” and “excited by the opportunities that lie ahead”. The shares have responded up to 73.5p, but why does that compare to above 180p as recently as July?…

LoopUp (LOOP) commences a trading statement with that it “expects both revenue and EBITDA for year ended 31 December 2021 to be broadly in line with market expectations” and adds “gross cash of £5.5 million”. So why currently a 10p share price, below £10 million market cap, more than 23% lower?…

Nuformix (NFX) “is pleased to announce that following the company’s signing of an exclusive global licensing agreement with Oxilio Ltd for NXP001 on 13 September 2021, Oxilio has progressed the product and signed a significant service contract”. What though of a 29% share price rise in response, to 1.3p here?…

Deltex Medical (DEMG) has announced that “the board has concluded that it is now appropriate to raise a total of approximately £1.4 million… at a price of 1.25 pence per Deltex Medical ordinary share… (i) to launch, market and commercialise the next generation TrueVue monitor as well as a new non-invasive Doppler probe; (ii) to provide the financial resources required to support the substantial grant funding already won… and (iii) for the general working capital needs of the business”. Really?…

Previously writing on transport data technology group when it was Maestrano, in October with the shares down to 13.5p I concluded there looked to still be much ‘growth trend’ work to do to justify the valuation and meanwhile there was also cash burn concern and I continued to avoid. The now Cordel Group (CRDL) has now announced results for its half-year ended 31st December 2021 including that “we have delivered positive progress with contract wins and exciting partnerships”. So why are the shares a further more than 10% lower to below 9p?…

Previously writing on “licensor of proprietary solutions improving the sustainability and economics of garments and fabrics” Xeros Technology (XSG), in September with the shares down to 185.5p I concluded the current record here doesn’t encourage. Still for me, a former Woodford dog and jam tomorrow avoid / sell. Today the group “is pleased to report on the progress which has been made by the group’s partners and licensees”, so why are the shares further lower towards 100p?…

Previously writing on self-described “leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products” Itaconix (ITX), last month as the shares rose to 6.25p I questioned new major application order from a leading European supplier, or not?, concluding caveat emptor, avoid / sell. The company now states that it “is pleased to update the market on trading for the full year to 31 December 2021”, so what of a further share price fall currently to 4.2p?…

Describing itself as “leading in-content advertising company” Mirriad Advertising (MIRI) has made a trading update and KPIs announcement headlined “Accelerating customer adoption and traction in the key US Market”. Why then currently a further share price fall towards 20p in response?…

Clothing, accessories and footwear company Superdry (SDRY) has announced results for its half-year ended 23rd October 2021 and a trading update for the subsequent 11 weeks, emphasising “clear signs of brand and financial recovery”. So what’s the story with the shares currently at circa 230p in response, 8% lower!…

‘Smart’ buildings and commercial spaces software company SmartSpace (SMRT) states that it “is pleased to announce a trading update… the group has been progressing its objective to build a high growth SaaS business with strong recurring revenues and consequently, expects that results for the full year ending 31 January 2022 will be in line with market expectations”. At a current 75p share price, why though are the shares down from above 180p as recently as July?…

CyanConnode (CYAN), which describes itself as “a world leader in Narrowband Radio Frequency Smart Mesh Networks”, states that it “is pleased to provide a trading update for the nine-month period ended 31 December 2021”. What then is it which sees the shares currently 3.5% lower below 21p?…

A trading update from mass spectrometry equipment company Microsaic Systems (MSYS) commences that “revenues for FY21 have significantly exceeded those of FY20, recovering to a level slightly ahead of that in FY19, a pre-pandemic benchmark” and includes CEO Glenn Tracey “absolutely delighted”. So what of a current share price response down to around 0.19p?…

On Monday on ‘digital chemistry data’ group DeepMatter (DMTR) as the shares fell below 0.70p I concluded hopefully our prior warnings were heeded, though still bargepole / sell. Hopefully at least that warning was heeded as now a Christmas Eve “Placing, Subscription and Open Offer”…

Describing itself as “a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products”, Itaconix (ITX) has announced that “successful” interim measures have enabled it to have “met and expects to continue to meet all customer orders” after water damage for which it has filed an insurance claim for property damage and operational costs incurred. What though of a current more than 33% higher share price response?…

Previously writing on ‘digital chemistry data’ group DeepMatter (DMTR), in September with the shares at 1.35p I concluded that ‘I suggest it doesn’t have adequate resources and funding arrangements ‘choice’ for long and still currently bargepole/sell’. The shares last closed at 1.05p… and now a “Business Update and Financing”-titled announcement and the shares currently below 0.70p!

A “Subscription to raise £1.65 million”-titled announcement from pharmaceutical company Nuformix (NFX), with its Chairman Dr Alastair Riddell emphasising “delighted by the confidence shown by Lanstead in the future prospects of the company’s products… products address large market opportunities. Importantly, this enables us to hire experienced business development expertise to build on our licensing opportunities for these products to pharmaceutical companies”. So why are the shares currently, at 1.20p, more than 14% lower?…

Previously writing on experience of digital services analytics company Actual Experience (ACT), in January with the shares at 118.5p I questioned placing “to capitalise on the current market opportunity”… or to avert liquidity crunch ahoy?. Today it commences a year-end trading update with that its “first full year operating our professional services ‘land and expand’ model has seen good progress, faster customer engagement and quicker software deployment”… so why a current 29% share price fall to 40p?!…

Biopharmaceutical data analytics company IXICO (IXI) has announced results for its year ended 30th September 2021 and the shares are currently more than 16% higher to 58.5p. However that compares to circa 84.5p when I previously wrote in October, so what’s the story now?…

Antibody contract research organisation Fusion Antibodies (FAB) has announced results for its half-year ended 30th September 2021 emphasising “20% underlying growth in revenues over H1 FY2021… and in particular the two major contracts which were secured which, taken together with the remaining pipeline of projects with other customers, give the board confidence that revenues for the full year will be in line with current expectations”. However, what is the financial impact of the revenue and what are the full year expectations?…

Marketing technology group Eagle Eye Solutions (EYE) has announced “revenue growth of 35% in Q1 versus the prior year, an increase from the Q4 FY21 growth of 27%. As a result, the board now expects adjusted EBITDA for the full year ending 30 June 2022 to be comfortably ahead of management expectations”… and the shares have currently responded circa 5% higher towards 600p. How does the valuation look?…

Biopharmaceutical data analytics company IXICO (IXI) has made a trading update including that year ended 30th September 2021 EBITDA is “expected to be materially ahead of market expectations of £1.2 million and prior year (2020: £1.3 million)”. Why then is the share price little changed at circa 84.5p?…

Previously writing on graphene nanoplatelets-based products company Directa Plus (DCTA), in June I concluded with the shares at 121.5p, having expressed cash burn concern, I continued to avoid. Today an “Additional Italian Government Covid Recovery Loan” announcement.

Maestrano (MNO) has announced results for its year ended 30th June 2021 and that it is “confident of continuing our current growth trend in FY22”. So why have the shares responded more than 5% further lower to 13.5p?…

Describing itself as “a world leader in Narrowband Radio Frequency Smart Mesh Networks”, CyanConnode (CYAN) states it “is pleased to provide a trading update for the six months ended 30 September 2021”. The shares have currently responded up towards 13p, but are still down from the more than 16p reached last month.

Previously writing on self-styled “leading provider of ‘safe distance’ people-screening technology to the international security market” Thruvision (THRU), in April with the shares at 22.4p I concluded whilst there should still be business suitability to the operating environment, with financial performance still to prove, I continue to avoid. Today the group “is pleased to provide an update on trading for the six months ended 30 September 2021” but the shares are again lower towards 20p, so what’s going on?…

Previously writing on Windar Photonics (WPHO), in December I concluded that I retained balance sheet concerns and still on the bargepole list. The shares rose significantly earlier this year but have since fallen significantly back again and are currently a further more than 11% lower, at 16p, on the back of half-year results the company argues show an “encouraging project pipeline”.

Osirium Technologies (OSI) has announced results for the first half of 2021, emphasising “good progress against our stated strategy… we are encouraged by the continued trading momentum as we enter the second half”. The shares have responded currently to 21.5p, 14% lower and a £6.3 million market cap, so what’s going on?…

Previously writing on Xeros Technology Group (XSG), in July with the shares higher to 232.5p I concluded at that juncture still a jam tomorrow avoid / sell. The shares last closed at 200p and the group has today announced results for the first half of 2021, emphasising “significant milestones with a number of market launches taking place”. So why are the shares currently at 185.5p?…